https://www.odoo.com/r/kr0
⭐️ Think School’s flagship Communication course with live doubt sessions :
https://thethinkschool.com/sp/communication-masterclass/
If you are a copyright owner and believe your work has been used improperly, please contact us at writers@thethinkschool.com for prompt removal or credit.
Follow Our Guests -
Jitendra Chouksey (JC): https://www.instagram.com/fittrwithjc/
Arjun Garewal: https://www.instagram.com/arjungarewal/
Dr. Muffazal Lakdawala: https://www.instagram.com/drmuffi/
Research reports cited by JC:
DPP trial - https://www.nejm.org/doi/full/10.1056/NEJMoa012512
Barbados study https://pmc.ncbi.nlm.nih.gov/articles/PMC8399825/
BMJ medical error study https://www.bmj.com/content/353/bmj.i2139
GLP-1 discontinuation Oxford study
https://www.ox.ac.uk/news/2026-01-08-new-study-finds-stopping-weight-loss-drugs-linked-faster-regain-ending-diet
VIDEO INTRODUCTION:
India is getting fatter, sicker and more diabetic every year.
And now, one injection promises to change everything.
GLP-1 drugs like Ozempic are being called a medical breakthrough. They can reduce appetite, accelerate weight loss and help patients control obesity and diabetes.
But critics believe these drugs could become a capitalist disaster. One that profits from unhealthy lifestyles while exposing millions of Indians to risks we still do not fully understand.
So, is Ozempic a miracle drug or a dangerous shortcut?
On one side is Jitendra Chouksey, Founder of FITTR. He believes obesity must primarily be tackled through lifestyle changes and questions the safety, regulation and long-term use of GLP-1 drugs.
On the other side are Dr Muffazal Lakdawala, one of India’s leading bariatric surgeons, and Arjun Garewal, a fitness consultant. They believe GLP-1 can transform lives when prescribed to the right patients and combined with proper nutrition, exercise and medical supervision.
One drug. Two opposing sides. A decision that could affect millions of Indians.
Miracle or disaster? Watch the debate and decide for yourself!
Chapters -
0:00 - Ozempic: Miracle or Capitalist Disaster?
3:34 - Meet Both Sides of the Ozempic Debate
4:36 - Why the Doctor Calls Ozempic a Game Changer
7:14 - Why JC Calls It a Capitalist Disaster
9:02 - Why Is the Richest Healthcare System the Sickest?
9:40 - Was Ozempic Really Tested on Indian Bodies?
10:18 - The Doctor Responds to the Trial Allegation
14:00 - Why Most People Cannot Sustain Lifestyle Changes
15:40 - Can India's Drug Regulators Be Trusted?
17:43 - Why Lifestyle Changes Alone May Not Be Enough
23:50 - The Doctor Challenges JC's Evidence
25:20 - Why Are Patients Quitting Ozempic?
28:14 - The Side Effects You Need to Know
31:00 - Can Today's Miracle Drug Become Tomorrow's Medical Mistake?
34:10 - Is the Dropout Rate a Warning Sign?
37:03 - Who Should Actually Take Ozempic?
46:34 - The Doctor's Final Verdict
47:46 - Arjun's Final Verdict
48:20 - JC's Final Warning
Watch our previous case studies on GLP1 -
India's Drug Goldmine : Can Ozempic make India rich?
https://www.youtube.com/watch?v=MTfrEo5duGQ&t=103s
Can OZEMPIC make INDIA RICH? | The ₹12,000 Crore Business OPPORTUNITY
https://www.youtube.com/watch?v=TDsuhPOMBKs
✅Study Materials:
Think School is a Digital School that we all deserved, but never had
►►Check out Think School's Online courses: https://www.thethinkschool.com
#ozempic #debate #thinkschool #medical #doctor #glp1 #mounjaro #fatloss #obesity